-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresec
November 01, 2017 - In evaluating the comparative effectiveness in metastatic disease, it is critical to evaluate patient-related
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - Stability
analysis
Performing discrete actions and evaluating
their impact on results. … Evaluating primary care behavioral
counseling interventions: an evidence-based
approach. … Empirically evaluating decision-analytic
models. Value Health. 2010 Aug;13(5):667-
74. … Evaluating the cost-effectiveness of
vaccination programmes: a dynamic
perspective. … Integration of meta-analysis and economic
decision modeling for evaluating diagnostic
tests.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - Can assess a body of evidence evaluating diagnostic test outcomes (e.g., diagnostic thinking, therapeutic … Adapted for Diagnostic Tests With Clinical Outcomes (1 of 2)
It is possible to assess a body of evidence evaluating … outcomes—such as diagnostic thinking, therapeutic choice, and clinical outcomes—in much the same way as evaluating … For example, a forest plot is often used to visually assess consistency when evaluating intervention … When evaluating diagnostic tests, directness would imply a head-to-head comparison of the test against
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - Can assess a body of evidence evaluating diagnostic test outcomes (e.g., diagnostic thinking, therapeutic … Adapted for Diagnostic Tests With Clinical Outcomes (1 of 2)
It is possible to assess a body of evidence evaluating … outcomes—such as diagnostic thinking, therapeutic choice, and clinical outcomes—in much the same way as evaluating … For example, a forest plot is often used to visually assess consistency when evaluating intervention … When evaluating diagnostic tests, directness would imply a head-to-head comparison of the test against
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - There
were few studies evaluating the new FXaIs. … Much of this lack is due to a
relative sparseness of evidence evaluating interventions
other than LMWH … majority of head-to-head
studies evaluated LMWH (enoxaparin, in particular) with
relatively few studies evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - There
were few studies evaluating the new FXaIs. … Much of this lack is due to a
relative sparseness of evidence evaluating interventions
other than LMWH … majority of head-to-head
studies evaluated LMWH (enoxaparin, in particular) with
relatively few studies evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
February 01, 2006 - Layout 1
Background
Breast cancer is the second most common
malignancy in women. The American
Cancer Society estimated that in the United
States in 2005, 212,930 women would be
newly diagnosed as having breast cancer
and there would be 40,870 deaths due to
this disease. Because early breast cancer is
asymptomatic, th…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/field-triage-glascow_research-protocol.pdf
February 25, 2016 - than or equal to 5
are considered to denote severe injury.11,12
There are a number of challenges in evaluating … assigned an overall grade of high, moderate, low, or
insufficient according to a four-level scale by evaluating … The injury severity score: a method for
describing patients with multiple injuries and evaluating emergency
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
June 15, 2011 - These criteria include an assessment of the risk of bias within each study by
specifically evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/telehealth_research-protocol.pdf
August 11, 2015 - convened a
group of Key Informants (KIs) with diverse experiences and perspectives in implementing
and evaluating … agencies, foundations, or professional associations that have been active in producing,
implementing, or evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
April 01, 2013 - not significantly different from control, these
findings may be misleading since many of the
trials evaluating … not significantly different from
control, these findings may be misleading since many of the
trials evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
January 01, 2011 - Most importantly, evaluating the process is instrumental for future planning. … Including measures
for evaluating how research dissemination efforts modify health practices and, where
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - being generated about new and established type 2 diabetes
medications, an updated systematic review evaluating … appropriate analyses for higher heterogeneity.31
We will attempt to determine reasons for heterogeneity by evaluating … Diabetes Mellitus -
Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
March 01, 2012 - Review
Number 50
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating … Antinuclear Antibody,
Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests
for Evaluating Musculoskeletal … more copies of Antinuclear Antibody, Rheumatoid
Factor, and Cyclic-Citrullinated Peptide Tests for
Evaluating
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - Evaluating medication effects outside of
clinical trials: new-user designs. … Evaluating short-term drug effects in claims
databases using physician-specific prescribing
preferences … Evaluating th eyield of medical tests. JAMA
1982;247:2543-6.
40 Barak Y, Shamir E; Weizman R.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
April 01, 2010 - When patients are
unable to self-report, the proxy evaluating the respiratory distress should be reported … apply indicators to
different disciplines and settings, such as whether standards should differ when evaluating … Evaluating claims-based indicators of the
intensity of end-of-life cancer care.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - I see that there are few pediatric data supporting the use of
any measurement device or survey for evaluating … excluded due to population
being healhty subjects without cough
or patients with acute cough in studies
evaluating … Unfortunately, few studies actually
documented a process for evaluating
and treating chronic cough
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-apbi-breast-cancer.pdf
April 01, 2017 - Three randomized trials evaluating APBI versus WBI
have been published or updated since the original … Data from other large randomized phase 3 trials
evaluating APBI, including the National Surgical Adjuvant … institution similarly showed a 2.6% 5-year risk of
IBTR.16 In addition, a single-institution study evaluating … Prospective multicenter trial
evaluating balloon-catheter partial-breast irradiation for ductal
carcinoma
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - Most of the CV events with celecoxib
were reported in two large polyp-prevention
trials evaluating 200 … dosage and duration of treatment on
the benefits and harms of oral medication use
• We found no studies evaluating … Given the large number of patients who meet
criteria for aspirin prophylaxis for CV events,
more trials evaluating … Studies evaluating the benefits and risks
associated with such strategies compared with
conventional
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/distributed-network-proof_research.pdf
June 01, 2010 - The health plans
differed regarding their internal policies and procedures for evaluating, approving